As of Nov 25
| +3.69 / +2.80%|
The 4 analysts offering 12-month price forecasts for USANA Health Sciences Inc have a median target of 162.00, with a high estimate of 200.00 and a low estimate of 131.00. The median estimate represents a +19.42% increase from the last price of 135.65.
The current consensus among 4 polled investment analysts is to Buy stock in USANA Health Sciences Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.